Abstract
Abstract The U.S. Food and Drug Administration approved 13 new cancer drugs in 2012, three of them via the accelerated approval process.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
